Survival, differentiation, and connectivity of ventral mesencephalic dopamine neurons following transplantation

Progress in Brain Research

Volumn 200, Issue , 2012, Pages 61-95

  Thompson, Lachlan ^a   Björklund, Anders ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Cell therapy; Midbrain; Parkinson's disease; Regeneration; Transplantation

Indexed keywords

DOPAMINE; SEROTONIN; TYROSINE 3 MONOOXYGENASE;

AGE; ARTICLE; BRAIN GRAFT; CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; CELL SUSPENSION; DOPAMINERGIC NERVE CELL; GRAFT SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; INNERVATION; LIMIT OF QUANTITATION; MESENCEPHALON; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; XENOGRAFT;

EID: 84870279696     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-59575-1.00004-1     Document Type: Chapter

References (143)

1. Abrous N., Guy J., Vigny A., Calas A., Le Moal M., Herman J.P. Development of intracerebral dopaminergic grafts: a combined immunohistochemical and autoradiographic study of its time course and environmental influences. J. Comp. Neurol. 1988, 273:26-41.
2. Aguayo A.J., Björklund A., Stenevi U., Carlstedt T. Fetal mesencephalic neurons survive and extend long axons across peripheral nervous system grafts inserted into the adult rat striatum. Neurosci. Lett. 1984, 45:53-58.
3. Baker-Cairns B.J., Sloan D.J., Broadwell R.D., Puklavec M., Charlton H.M. Contributions of donor and host blood vessels in CNS allografts. Exp. Neurol. 1996, 142:36-46.
4. Barker R.A., Fricker R.A., Abrous D.N., Fawcett J., Dunnett S.B. A comparative study of preparation techniques for improving the viability of nigral grafts using vital stains, in vitro cultures, and in vivo grafts. Cell Transplant. 1995, 4:173-200.
5. Barker R.A., Dunnett S.B., Faissner A., Fawcett J.W. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp. Neurol. 1996, 141:79-93.
6. Beckstead R.M., Domesick V.B., Nauta W.J. Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 1979, 175:191-217.
7. Bentlage C., Nikkhah G., Cunningham M.G., Björklund A. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host. Exp. Neurol. 1999, 159:177-190.
8. Björklund A., Dunnett S.B. Dopamine neuron systems in the brain: an update. Trends Neurosci. 2007, 30:194-202.
9. Björklund A., Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 1979, 177:555-560.
10. Björklund A., Stenevi U., Schmidt R.H., Dunnett S.B., Gage F.H. Intracerebral grafting of neuronal cell suspensions. I. Introduction and general methods of preparation. Acta Physiol. Scand. Suppl. 1983, 522:1-7.
11. Björklund A., Stenevi U., Schmidt R.H., Dunnett S.B., Gage F.H. Intracerebral grafting of neuronal cell suspensions. II. Survival and growth of nigral cell suspensions implanted in different brain sites. Acta Physiol. Scand. Suppl. 1983, 522:9-18.
12. Bolam J.P., Freund T.F., Björklund A., Dunnett S.B., Smith A.D. Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host neostriatum. Exp. Brain Res. 1987, 68:131-146.
13. Brecknell J.E., Haque N.S., Du J.S., Muir E.M., Fidler P.S., Hlavin M.L., Fawcett J.W., Dunnett S.B. Functional and anatomical reconstruction of the 6-hydroxydopamine lesioned nigrostriatal system of the adult rat. Neuroscience 1996, 71:913-925.
14. Broadwell R.D., Charlton H.M., Ebert P., Hickey W.F., Villegas J.C., Wolf A.L. Angiogenesis and the blood-brain barrier in solid and dissociated cell grafts within the CNS. Prog. Brain Res. 1990, 82:95-101.
15. Brundin P., Björklund A. Survival, growth and function of dopaminergic neurons grafted to the brain. Prog. Brain Res. 1987, 71:293-308.
16. Brundin P., Barbin G., Isacson O., Mallat M., Chamak B., Prochiantz A., Gage F.H., Björklund A. Survival of intracerebrally grafted rat dopamine neurons previously cultured in vitro. Neurosci. Lett. 1985, 61:79-84.
17. Brundin P., Isacson O., Björklund A. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 1985, 331:251-259.
18. Brundin P., Strecker R.E., Londos E., Björklund A. Dopamine neurons grafted unilaterally to the nucleus accumbens affect drug-induced circling and locomotion. Exp. Brain Res. 1987, 69:183-194.
19. Brundin P., Strecker R.E., Widner H., Clarke D.J., Nilsson O.G., Astedt B., Lindvall O., Björklund A. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp. Brain Res. 1988, 70:192-208.
20. Brundin P., Björklund A., Lindvall O. Practical aspects of the use of human fetal brain tissue for intracerebral grafting. Prog. Brain Res. 1990, 82:707-714.
21. Brundin P., Duan W.M., Sauer H. Functional effects of mesencephalic dopamine neurons and adrenal chromaffin cells grafted to the rodent striatum. Functional Neural Transplantation 1994, 9-46. Raven Press, New York. S.B. Dunnett, A. Björklund (Eds.).
22. Brundin P., Karlsson J., Emgard M., Schierle G.S., Hansson O., Petersen A., Castilho R.F. Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant. 2000, 9:179-195.
23. Bustos G., Abarca J., Campusano J., Bustos V., Noriega V., Aliaga E. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain. Brain Res. Brain Res. Rev. 2004, 47:126-144.
24. Bye C.R., Thompson L.H., Parish C.L. Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into Parkinsonian mice. Exp. Neurol. 2012, 236:58-68.
25. Carlsson T., Carta M., Winkler C., Björklund A., Kirik D. Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease. J. Neurosci. 2007, 27:8011-8022.
26. Carlsson T., Carta M., Munoz A., Mattsson B., Winkler C., Kirik D., Björklund A. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in Parkinsonian rats is determined by the extent of dopamine neuron degeneration. Brain 2009, 132:319-335.
27. Carta M., Carlsson T., Kirik D., Björklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in Parkinsonian rats. Brain 2007, 130:1819-1833.
28. Collier T.J., Sortwell C.E., Daley B.F. Diminished viability, growth, and behavioral efficacy of fetal dopamine neuron grafts in aging rats with long-term dopamine depletion: an argument for neurotrophic supplementation. J. Neurosci. 1999, 19:5563-5573.
29. Cornwall J., Phillipson O.T. Afferent projections to the dorsal thalamus of the rat as shown by retrograde lectin transport-I. The mediodorsal nucleus. Neuroscience 1988, 24:1035-1049.
30. Dahlstrom A., Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 1964, 62(Suppl. 232):231-255.
31. Doucet G., Murata Y., Brundin P., Bosler O., Mons N., Geffard M., Ouimet C.C., Björklund A. Host afferents into intrastriatal transplants of fetal ventral mesencephalon. Exp. Neurol. 1989, 106:1-19.
32. Doucet G., Brundin P., Descarries L., Björklund A. Effect of prior dopamine denervation on survival and fiber outgrowth from intrastriatal fetal mesencephalic grafts. Eur. J. Neurosci. 1990, 2:279-290.
33. Duan W.M., Widner H., Brundin P. Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats. Exp. Brain Res. 1995, 104:227-242.
34. Dunnett S.B., Björklund A., Schmidt R.H., Stenevi U., Iversen S.D. Intracerebral grafting of neuronal cell suspensions. IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiol. Scand. Suppl. 1983, 522:29-37.
35. Dunnett S.B., Hernandez T.D., Summerfield A., Jones G.H., Arbuthnott G. Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues. Exp. Brain Res. 1988, 71:411-424.
36. Dunnett S.B., Björklund A., Lindvall O. Cell therapy in Parkinson's disease-stop or go?. Nat. Rev. Neurosci. 2001, 2:365-369.
37. Emgard M., Karlsson J., Hansson O., Brundin P. Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts. Exp. Neurol. 1999, 160:279-288.
38. Fallon J.H., Moore R.Y. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp. Neurol. 1978, 180:545-580.
39. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114(Pt 5):2283-2301.
40. Fisher L.J., Young S.J., Tepper J.M., Groves P.M., Gage F.H. Electrophysiological characteristics of cells within mesencephalon suspension grafts. Neuroscience 1991, 40:109-122.
41. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 2001, 344:710-719.
42. Freund T.F., Bolam J.P., Björklund A., Stenevi U., Dunnett S.B., Powell J.F., Smith A.D. Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study. J. Neurosci. 1985, 5:603-616.
43. Frodl E.M., Duan W.M., Sauer H., Kupsch A., Brundin P. Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function. Brain Res. 1994, 647:286-298.
44. Gage F.H., Björklund A., Stenevi U., Dunnett S.B. Intracerebral grafting of neuronal cell suspensions. VIII. Survival and growth of implants of nigral and septal cell suspensions in intact brains of aged rats. Acta Physiol. Scand. Suppl. 1983, 522:67-75.
45. Gage F.H., Stenevi U., Carlstedt T., Foster G., Björklund A., Aguayo A.J. Anatomical and functional consequences of grafting mesencephalic neurons into a peripheral nerve "bridge" connected to the denervated striatum. Exp. Brain Res. 1985, 60:584-589.
46. Gaillard A., Decressac M., Frappe I., Fernagut P.O., Prestoz L., Besnard S., Jaber M. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants. Neurobiol. Dis. 2009, 35:477-488.
47. Garcia J., Carlsson T., Dobrossy M., Nikkhah G., Winkler C. Impact of dopamine to serotonin cell ratio in transplants on behavioral recovery and L-DOPA-induced dyskinesia. Neurobiol. Dis. 2011, 43:576-587.
48. Gates M.A., Torres E.M., White A., Fricker-Gates R.A., Dunnett S.B. Re-examining the ontogeny of substantia nigra dopamine neurons. Eur. J. Neurosci. 2006, 23:1384-1390.
49. German D.C., Schlusselberg D.S., Woodward D.J. Three-dimensional computer reconstruction of midbrain dopaminergic neuronal populations: from mouse to man. J. Neural Transm. 1983, 57:243-254.
50. German D.C., Manaye K., Smith W.K., Woodward D.J., Saper C.B. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann. Neurol. 1989, 26:507-514.
51. Grealish S., Jonsson M.E., Li M., Kirik D., Björklund A., Thompson L.H. The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease. Brain 2010, 133:482-495.
52. Hagell P., Brundin P. Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J. Neuropathol. Exp. Neurol. 2001, 60:741-752.
53. Herman J.P., Abrous N.D. Dopaminergic neural grafts after fifteen years: results and perspectives. Prog. Neurobiol. 1994, 44:1-35.
54. Hidalgo A., Brand A.H. Targeted neuronal ablation: the role of pioneer neurons in guidance and fasciculation in the CNS of Drosophila. Development 1997, 124:3253-3262.
55. Hornykiewicz O. Brain monoamines and parkinsonism. Natl. Inst. Drug Abuse Res. Monogr. Ser. 1975, 3:13-21.
56. Hudson J.L., Bickford P., Johansson M., Hoffer B.J., Strömberg I. Target and neurotransmitter specificity of fetal central nervous system transplants: importance for functional reinnervation. J. Neurosci. 1994, 14:283-290.
57. Isacson O., Deacon T.W. Specific axon guidance factors persist in the adult brain as demonstrated by pig neuroblasts transplanted to the rat. Neuroscience 1996, 75:827-837.
58. Isacson O., Deacon T.W., Pakzaban P., Galpern W.R., Dinsmore J., Burns L.H. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nat. Med. 1995, 1:1189-1194.
59. Janec E., Burke R.E. Naturally occurring cell death during postnatal development of the substantia nigra pars compacta of rat. Mol. Cell. Neurosci. 1993, 4:30-35.
60. Joksimovic M., Anderegg A., Roy A., Campochiaro L., Yun B., Kittappa R., McKay R., Awatramani R. Spatiotemporally separable Shh domains in the midbrain define distinct dopaminergic progenitor pools. Proc. Natl. Acad. Sci. USA 2009, 106:19185-19190.
61. Jonsson M.E., Ono Y., Björklund A., Thompson L.H. Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis. Exp. Neurol. 2009, 219:341-354.
62. Kirik D., Winkler C., Björklund A. Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. J. Neurosci. 2001, 21:2889-2896.
63. Kish S.J., Shannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N. Engl. J. Med. 1988, 318:876-880.
64. Klose M., Bentley D. Transient pioneer neurons are essential for formation of an embryonic peripheral nerve. Science 1989, 245:982-984.
65. Kordower J.H., Rosenstein J.M., Collier T.J., Burke M.A., Chen E.Y., Li J.M., Martel L., Levey A.E., Mufson E.J., Freeman T.B., Olanow C.W. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 1996, 370:203-230.
66. Kordower J.H., Freeman T.B., Chen E.Y., Mufson E.J., Sanberg P.R., Hauser R.A., Snow B., Olanow C.W. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov. Disord. 1998, 13:383-393.
67. Kornblum H.I., Hussain R.J., Bronstein J.M., Gall C.M., Lee D.C., Seroogy K.B. Prenatal ontogeny of the epidermal growth factor receptor and its ligand, transforming growth factor alpha, in the rat brain. J. Comp. Neurol. 1997, 380:243-261.
68. Kuan W.L., Lin R., Tyers P., Barker R.A. The importance of A9 dopaminergic neurons in mediating the functional benefits of fetal ventral mesencephalon transplants and levodopa-induced dyskinesias. Neurobiol. Dis. 2007, 25:594-608.
69. Lane E.L., Björklund A., Dunnett S.B., Winkler C. Neural grafting in Parkinson's disease unraveling the mechanisms underlying graft-induced dyskinesia. Prog. Brain Res. 2010, 184:295-309.
70. Lin D.M., Auld V.J., Goodman C.S. Targeted neuronal cell ablation in the Drosophila embryo: pathfinding by follower growth cones in the absence of pioneers. Neuron 1995, 14:707-715.
71. Lindvall O., Björklund A. Cell therapy in Parkinson's disease. NeuroRx 2004, 1:382-393.
72. Lindvall O., Hagell P. Clinical observations after neural transplantation in Parkinson's disease. Prog. Brain Res. 2000, 127:299-320.
73. Llambi F., Causeret F., Bloch-Gallego E., Mehlen P. Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J. 2001, 20:2715-2722.
74. Lundberg C., Wictorin K., Björklund A. Retrograde degenerative changes in the substantia nigra pars compacta following an excitotoxic lesion of the striatum. Brain Res. 1994, 644:205-212.
75. Mahalik T.J., Clayton G.H. Specific outgrowth from neurons of ventral mesencephalic grafts to the catecholamine-depleted striatum of adult hosts. Exp. Neurol. 1991, 113:18-27.
76. McConnell S.K., Ghosh A., Shatz C.J. Subplate neurons pioneer the first axon pathway from the cerebral cortex. Science 1989, 245:978-982.
77. McConnell S.K., Ghosh A., Shatz C.J. Subplate pioneers and the formation of descending connections from cerebral cortex. J. Neurosci. 1994, 14:1892-1907.
78. Mehlen P., Mazelin L. The dependence receptors DCC and UNC5H as a link between neuronal guidance and survival. Biol. cell 2003, 95:425-436.
79. Mendez I., Sanchez-Pernaute R., Cooper O., Vinuela A., Ferrari D., Björklund L., Dagher A., Isacson O. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 2005, 128:1498-1510.
80. Molnar Z., Adams R., Blakemore C. Mechanisms underlying the early establishment of thalamocortical connections in the rat. J. Neurosci. 1998, 18:5723-5745.
81. Nakao N., Frodl E.M., Duan W.M., Widner H., Brundin P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl. Acad. Sci. USA 1994, 91:12408-12412.
82. Nakao N., Frodl E.M., Widner H., Carlson E., Eggerding F.A., Epstein C.J., Brundin P. Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nat. Med. 1995, 1:226-231.
83. Nikkhah G., Duan W.M., Knappe U., Jodicke A., Björklund A. Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model. Neuroscience 1993, 56:33-43.
84. Nikkhah G., Bentlage C., Cunningham M.G., Björklund A. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. J. Neurosci. 1994, 14:3449-3461.
85. Nikkhah G., Cunningham M.G., Jodicke A., Knappe U., Björklund A. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res. 1994, 633:133-143.
86. Nikkhah G., Winkler C., Rödter A., Samii M. Microtransplantation of nigral dopamine neurons: a "step by step" recipe. Neuromethods: Cell and Tissue Transplantation in the CNS 2000, 207-231. The Human Press, Totowa. S.B. Dunnett, A.A. Boulton, G.B. Baker (Eds.).
87. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., Shannon K.M., Nauert G.M., Perl D.P., Godbold J., Freeman T.B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 2003, 54:403-414.
88. Olson L., Seiger A., Strömberg I. Intraocular Transplantation in Rodents: A Detailed Account of the Procedure and Examples of Its Use in Neurobiology with Special Reference to Brain Tissue Grafting 1983, Academic Press, New York.
89. Pakkenberg B., Moller A., Gundersen H.J., Mouritzen Dam A., Pakkenberg H. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J. Neurol. Neurosurg. Psychiatry 1991, 54:30-33.
90. Perlow M.J., Freed W.J., Hoffer B.J., Seiger A., Olson L., Wyatt R.J. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 1979, 204:643-647.
91. Piccini P., Pavese N., Hagell P., Reimer J., Björklund A., Oertel W.H., Quinn N.P., Brooks D.J., Lindvall O. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain 2005, 128:2977-2986.
92. Pittman A.J., Law M.Y., Chien C.B. Pathfinding in a large vertebrate axon tract: isotypic interactions guide retinotectal axons at multiple choice points. Development 2008, 135:2865-2871.
93. Politis M., Wu K., Loane C., Quinn N.P., Brooks D.J., Rehncrona S., Björklund A., Lindvall O., Piccini P. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci. Transl. Med. 2010, 2:38ra46.
94. Politis M., Oertel W.H., Wu K., Quinn N.P., Pogarell O., Brooks D.J., Björklund A., Lindvall O., Piccini P. Graft-induced dyskinesias in Parkinson's disease: high striatal serotonin/dopamine transporter ratio. Mov. Disord. 2011, 26:1997-2003.
95. Redmond D.E., Vinuela A., Kordower J.H., Isacson O. Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease. Neurobiol. Dis. 2008, 29:103-116.
96. Redmond D.E., Elsworth J.D., Roth R.H., Leranth C., Collier T.J., Blanchard B., Bjugstad K.B., Samulski R.J., Aebischer P., Sladek J.R. Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non-human primate after overexpression of GDNF. J. Comp. Neurol. 2009, 515:31-40.
97. Reyes S., Fu Y., Double K., Thompson L., Kirik D., Paxinos G., Halliday G.M. GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area. J. Comp. Neurol. 2012, 520:2591-2607.
98. Rosenblad C., Martinez-Serrano A., Björklund A. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience 1996, 75:979-985.
99. Sauer H., Frodl E.M., Kupsch A., ten Bruggencate G., Oertel W.H. Cryopreservation, survival and function of intrastriatal fetal mesencephalic grafts in a rat model of Parkinson's disease. Exp. Brain Res. 1992, 90:54-62.
100. Sautter J., Tseng J.L., Braguglia D., Aebischer P., Spenger C., Seiler R.W., Widmer H.R., Zurn A.D. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts. Exp. Neurol. 1998, 149:230-236.
101. Sawamoto K., Nakao N., Kobayashi K., Matsushita N., Takahashi H., Kakishita K., Yamamoto A., Yoshizaki T., Terashima T., Murakami F., Itakura T., Okano H. Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons. Proc. Natl. Acad. Sci. USA 2001, 98:6423-6428.
102. Schaar D.G., Sieber B.A., Dreyfus C.F., Black I.B. Regional and cell-specific expression of GDNF in rat brain. Exp. Neurol. 1993, 124:368-371.
103. Schierle G.S., Hansson O., Leist M., Nicotera P., Widner H., Brundin P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat. Med. 1999, 5:97-100.
104. Schierle G.S., Leist M., Martinou J.C., Widner H., Nicotera P., Brundin P. Differential effects of Bcl-2 overexpression on fibre outgrowth and survival of embryonic dopaminergic neurons in intracerebral transplants. Eur. J. Neurosci. 1999, 11:3073-3081.
105. Seroogy K.B., Lundgren K.H., Lee D.C., Guthrie K.M., Gall C.M. Cellular localization of transforming growth factor-alpha mRNA in rat forebrain. J. Neurochem. 1993, 60:1777-1782.
106. Shibata H. Topographic organization of subcortical projections to the anterior thalamic nuclei in the rat. J. Comp. Neurol. 1992, 323:117-127.
107. Simonds G.R., Freed W.J. Effects of intraventricular substantia nigra allografts as a function of donor age. Brain Res. 1990, 530:12-19.
108. Sinclair S.R., Svendsen C.N., Torres E.M., Martin D., Fawcett J.W., Dunnett S.B. GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. Neuroreport 1996, 7:2547-2552.
109. Sinclair S.R., Fawcett J.W., Dunnett S.B. Delayed implantation of nigral grafts improves survival of dopamine neurones and rate of functional recovery. Neuroreport 1999, 10:1263-1267.
110. Sinclair S.R., Fawcett J.W., Dunnett S.B. Dopamine cells in nigral grafts differentiate prior to implantation. Eur. J. Neurosci. 1999, 11:4341-4348.
111. Smidt M.P., Smits S.M., Bouwmeester H., Hamers F.P., van der Linden A.J., Hellemons A.J., Graw J., Burbach J.P. Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development 2004, 131:1145-1155.
112. Sorensen A.T., Thompson L., Kirik D., Björklund A., Lindvall O., Kokaia M. Functional properties and synaptic integration of genetically labelled dopaminergic neurons in intrastriatal grafts. Eur. J. Neurosci. 2005, 21:2793-2799.
113. Sortwell C.E. Strategies for the augmentation of grafted dopamine neuron survival. Front. Biosci. 2003, 8:s522-s532.
114. Sortwell C.E., Camargo M.D., Pitzer M.R., Gyawali S., Collier T.J. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval. Exp. Neurol. 2001, 169:23-29.
115. Stenevi U., Björklund A., Svendgaard N.A. Transplantation of central and peripheral monoamine neurons to the adult rat brain: techniques and conditions for survival. Brain Res. 1976, 114:1-20.
116. Stenevi U., Kromer L.F., Gage F.H., Björklund A. Solid neural grafts in intracerebral transplantation cavities. Neural Grafting m the Mammalian CNS 1985, 41-49. Elsevier, Amsterdam. A. Björklund, U. Stenevi (Eds.).
117. Strecker R.E., Sharp T., Brundin P., Zetterstrom T., Ungerstedt U., Björklund A. Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis. Neuroscience 1987, 22:169-178.
118. Strömberg I., Björklund L., Johansson M., Tomac A., Collins F., Olson L., Hoffer B., Humpel C. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 1993, 124:401-412.
119. Sullivan A.M., Pohl J., Blunt S.B. Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease. Eur. J. Neurosci. 1998, 10:3681-3688.
120. Takeshima T., Johnston J.M., Commissiong J.W. Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation. J. Neurosci. 1994, 14:4769-4779.
121. Thompson L.H., Björklund A. Transgenic reporter mice as tools for studies of transplantability and connectivity of dopamine neuron precursors in fetal tissue grafts. Prog. Brain Res. 2009, 175:53-79.
122. Thompson L., Barraud P., Andersson E., Kirik D., Björklund A. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J. Neurosci. 2005, 25:6467-6477.
123. Thompson L.H., Andersson E., Jensen J.B., Barraud P., Guillemot F., Parmar M., Björklund A. Neurogenin2 identifies a transplantable dopamine neuron precursor in the developing ventral mesencephalon. Exp. Neurol. 2006, 198:183-198.
124. Thompson L.H., Kirik D., Björklund A. Non-dopaminergic neurons in ventral mesencephalic transplants make widespread axonal connections in the host brain. Exp. Neurol. 2008, 213:220-228.
125. Thompson L.H., Grealish S., Kirik D., Björklund A. Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain. Eur. J. Neurosci. 2009, 30:625-638.
126. Torres E.M., Monville C., Lowenstein P.R., Castro M.G., Dunnett S.B. Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor age. Brain Res. Bull. 2005, 68:31-41.
127. Torres E.M., Monville C., Gates M.A., Bagga V., Dunnett S.B. Improved survival of young donor age dopamine grafts in a rat model of Parkinson's disease. Neuroscience 2007, 146:1606-1617.
128. Wictorin K., Brundin P., Sauer H., Lindvall O., Björklund A. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats. J. Comp. Neurol. 1992, 323:475-494.
129. Widenfalk J., Nosrat C., Tomac A., Westphal H., Hoffer B., Olson L. Neurturin and glial cell line-derived neurotrophic factor receptor-beta (GDNFR-beta), novel proteins related to GDNF and GDNFR-alpha with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs. J. Neurosci. 1997, 17:8506-8519.
130. Wilby M.J., Sinclair S.R., Muir E.M., Zietlow R., Adcock K.H., Horellou P., Rogers J.H., Dunnett S.B., Fawcett J.W. A glial cell line-derived neurotrophic factor-secreting clone of the Schwann cell line SCTM41 enhances survival and fiber outgrowth from embryonic nigral neurons grafted to the striatum and to the lesioned substantia nigra. J. Neurosci. 1999, 19:2301-2312.
131. Williams M.N., Faull R.L. The striatonigral projection and nigrotectal neurons in the rat. A correlated light and electron microscopic study demonstrating a monosynaptic striatal input to identified nigrotectal neurons using a combined degeneration and horseradish peroxidase procedure. Neuroscience 1985, 14:991-1010.
132. Winkler C., Bentlage C., Nikkhah G., Samii M., Björklund A. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Exp. Neurol. 1999, 155:165-186.
133. Winkler C., Kirik D., Björklund A., Dunnett S.B. Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement. Prog. Brain Res. 2000, 127:233-265.
134. Winkler C., Bentlage C., Cenci M.A., Nikkhah G., Björklund A. Regulation of neuropeptide mRNA expression in the basal ganglia by intrastriatal and intranigral transplants in the rat Parkinson model. Neuroscience 2003, 118:1063-1077.
135. Winkler C., Kirik D., Björklund A. Cell transplantation in Parkinson's disease: how can we make it work?. Trends Neurosci. 2005, 28:86-92.
136. Wright A.K., Arbuthnott G.W., Dunnett S.B. Serotonin hyperinnervation after foetal nigra or raphe transplantation in the neostriatum of adult rats. Neurosci. Lett. 1991, 128:281-284.
137. Yurek D.M. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue. Exp. Neurol. 1998, 153:195-202.
138. Yurek D.M., Fletcher-Turner A. Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion. Brain Res. 2001, 891:228-235.
139. Zeng B.Y., Jenner P., Marsden C.D. Altered motor function and graft survival produced by basic fibroblast growth factor in rats with 6-OHDA lesions and fetal ventral mesencephalic grafts are associated with glial proliferation. Exp. Neurol. 1996, 139:214-226.
140. Zetterstrom T., Brundin P., Gage F.H., Sharp T., Isacson O., Dunnett S.B., Ungerstedt U., Björklund A. In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis. Brain Res. 1986, 362:344-349.
141. Zhao S., Maxwell S., Jimenez-Beristain A., Vives J., Kuehner E., Zhao J., O'Brien C., de Felipe C., Semina E., Li M. Generation of embryonic stem cells and transgenic mice expressing green fluorescence protein in midbrain dopaminergic neurons. Eur. J. Neurosci. 2004, 19:1133-1140.
142. Zhou J., Pliego-Rivero B., Bradford H.F., Stern G.M. The BDNF content of postnatal and adult rat brain: the effects of 6-hydroxydopamine lesions in adult brain. Brain Res. Dev. Brain Res. 1996, 97:297-303.
143. Zuddas A., Corsini G.U., Barker J.L., Kopin I.J., Di Porzio U. Specific reinnervation of lesioned mouse striatum by grafted mesencephalic dopaminergic neurons. Eur. J. Neurosci. 1991, 3:72-85.